Lowering the Cardiovascular Burden With Novel Weight Loss Therapies: An Expert Digest From ESC

What do ESC 2024 data mean for reducing cardiovascular risk in clinical practice with incretin-based agents?

Credit available for this activity expires: 9/24/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001648?ecd=bdc_podcast_libsyn_mscpedu